218 related articles for article (PubMed ID: 26583330)
1. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2.
Sun R; Jiang B; Qi H; Zhang X; Yang J; Duan J; Li Y; Li G
Cell Death Dis; 2015 Nov; 6(11):e1990. PubMed ID: 26583330
[TBL] [Abstract][Full Text] [Related]
2. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
3. ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines.
Tang Y; Hou J; Li G; Song Z; Li X; Yang C; Liu W; Hu Y; Xu Y
Oncol Rep; 2014 Nov; 32(5):2168-74. PubMed ID: 25200103
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
[TBL] [Abstract][Full Text] [Related]
5. Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4.
Yuan LY; Zhou M; Lv H; Qin X; Zhou J; Mao X; Li X; Xu Y; Liu Y; Xing H
J Cell Physiol; 2019 Aug; 234(10):18985-18993. PubMed ID: 30932200
[TBL] [Abstract][Full Text] [Related]
6. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
8. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
[TBL] [Abstract][Full Text] [Related]
9. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ABCG2 inhibits cancer cell proliferation.
Chen Z; Liu F; Ren Q; Zhao Q; Ren H; Lu S; Zhang L; Han Z
Int J Cancer; 2010 Feb; 126(4):841-51. PubMed ID: 19642144
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated SOX4 expression suppresses cell proliferation, metastasis and induces apoptosis in Xuanwei female lung cancer patients.
Zhou Y; Wang X; Huang Y; Chen Y; Zhao G; Yao Q; Jin C; Huang Y; Liu X; Li G
J Cell Biochem; 2015 Jun; 116(6):1007-18. PubMed ID: 25565486
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
[TBL] [Abstract][Full Text] [Related]
14. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
Ding XW; Wu JH; Jiang CP
Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
[TBL] [Abstract][Full Text] [Related]
15. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
Li R; Liu GZ; Luo SY; Chen R; Zhang JX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
[TBL] [Abstract][Full Text] [Related]
16. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.
Hamada S; Satoh K; Hirota M; Kanno A; Umino J; Ito H; Masamune A; Kikuta K; Kume K; Shimosegawa T
J Cell Physiol; 2012 Feb; 227(2):729-38. PubMed ID: 21465479
[TBL] [Abstract][Full Text] [Related]
17. PLAC8 contributes to the malignant behaviors of cervical cancer cells by activating the SOX4-mediated AKT pathway.
Deng B; Zhang S; Zhou Y; Zhu Y; Fei J; Li A
Histochem Cell Biol; 2023 May; 159(5):439-451. PubMed ID: 36602585
[TBL] [Abstract][Full Text] [Related]
18. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.
Mosaffa F; Kalalinia F; Lage H; Afshari JT; Behravan J
Mol Cell Biochem; 2012 Apr; 363(1-2):385-93. PubMed ID: 22193459
[TBL] [Abstract][Full Text] [Related]
19. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
To KK; Yu L; Liu S; Fu J; Cho CH
Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
[TBL] [Abstract][Full Text] [Related]
20. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells.
Ke SZ; Ni XY; Zhang YH; Wang YN; Wu B; Gao FG
Int J Oncol; 2013 Apr; 42(4):1289-96. PubMed ID: 23381786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]